US Broker Ratings

GRAIL, Inc. (GRAL): Investor Outlook on a High-Stakes Healthcare Innovator

GRAIL, Inc. (NASDAQ: GRAL) is at the forefront of the healthcare sector, specifically within the diagnostics and research industry. Based in Menlo Park, California, GRAIL is..

CRISPR Therapeutics AG (CRSP) Stock Analysis: 59% Potential Upside Amid Rapid Revenue Growth

CRISPR Therapeutics AG (NASDAQ: CRSP), a pioneering entity in the biotechnology sector, has been making waves with its groundbreaking work in gene editing. Headquartered in Zug,..

AtriCure, Inc. (ATRC) Stock Analysis: Exploring a 36.9% Potential Upside for Investors

AtriCure, Inc. (NASDAQ: ATRC) stands as a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. Headquartered in Mason, Ohio, AtriCure..

Mesoblast Limited (MESO) Stock Analysis: Exploring a 124% Potential Upside in the Biotechnology Arena

Investors with an eye on the healthcare sector might find Mesoblast Limited (NASDAQ: MESO) intriguing, especially given its substantial growth potential. The Melbourne-based biotechnology company, known..

Arcutis Biotherapeutics, Inc. (ARQT) Stock Analysis: Impressive Revenue Growth Amidst High Forward P/E

Arcutis Biotherapeutics, Inc. (ARQT) is making waves in the biotechnology sector with its focus on innovative treatments for dermatological diseases. Based in Westlake Village, California, this..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: A 15.12% Potential Upside in the Healthcare Sector

Alphatec Holdings, Inc. (NYSE: ATEC), a prominent player in the medical devices industry, specializes in innovative technologies for the surgical treatment of spinal disorders. With a..

National HealthCare Corporation (NHC) Stock Analysis: A Steady Performer with 12.5% Revenue Growth in the Healthcare Sector

National HealthCare Corporation (NYSE: NHC) has established itself as a prominent player in the healthcare sector, specializing in medical care facilities across the United States. With..

Denali Therapeutics (DNLI) Stock Analysis: A 69% Potential Upside in Neurodegenerative Treatment Innovations

Denali Therapeutics Inc. (NASDAQ: DNLI) is capturing the attention of investors with its innovative approach to treating neurodegenerative and lysosomal storage diseases. With a market capitalization..

LivaNova PLC (LIVN) Stock Analysis: Exploring a 14.29% Upside Amidst Strong Revenue Growth

LivaNova PLC (NASDAQ: LIVN), a prominent player in the healthcare sector, is garnering attention from investors due to its notable position in the medical devices industry...

Janux Therapeutics, Inc. (JANX) Stock Analysis: Exploring 144.79% Potential Upside in Biotech Innovation

Investors seeking opportunities within the burgeoning biotech sector might find Janux Therapeutics, Inc. (NASDAQ: JANX) particularly compelling. With a market capitalization of $1.9 billion, Janux is..

HUTCHMED (China) Limited (HCM) Investor Outlook: Unpacking a 58.53% Potential Upside

HUTCHMED (China) Limited (HCM) represents a compelling opportunity for investors interested in the dynamic field of biotechnology and pharmaceuticals. With its specialization in developing and commercializing..

Scholar Rock Holding Corporation (SRRK) Stock Analysis: Exploring a Promising 13% Upside Potential in Biotechnology

In the dynamic world of biotechnology, Scholar Rock Holding Corporation (NASDAQ: SRRK) presents an intriguing opportunity for investors focused on innovation-driven growth. With a market capitalization..

Premier, Inc. (PINC) Stock Analysis: Exploring the 2.97% Dividend Yield Amidst Market Challenges

Investors eyeing the healthcare sector might want to take a closer look at Premier, Inc. (NASDAQ: PINC), a notable player in the health information services industry...

DENTSPLY SIRONA Inc. (XRAY) Stock Analysis: Exploring the 20.82% Potential Upside

DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a stalwart in the healthcare sector with a focus on medical instruments and supplies, is currently drawing investor attention with a..

Haemonetics Corporation (HAE) Stock Analysis: A Look at the 6.16% Potential Upside Amid Robust Analyst Support

Haemonetics Corporation (NYSE: HAE), a notable player in the healthcare sector, continues to attract investor interest with its innovative suite of medical technologies and a promising..

Supernus Pharmaceuticals, Inc. (SUPN): Investor Outlook Reveals 34% Potential Upside

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) is emerging as a notable player in the healthcare sector, particularly within the specialized drug manufacturing industry. Based in Rockville, Maryland,..

ImmunityBio, Inc. (IBRX) Stock Analysis: Unveiling a 374% Potential Upside with Strong Buy Ratings

ImmunityBio, Inc. (NASDAQ: IBRX) has emerged as a compelling player in the biotechnology sector, captivating investor attention with its robust potential upside of 374.42%. Headquartered in..

Certara, Inc. (CERT) Stock Analysis: Potential 49% Upside Beckons Healthcare Investors

Certara, Inc. (NASDAQ: CERT), a leader in the healthcare sector’s health information services industry, offers investors a compelling narrative as it navigates through the complexities of..

Concentra Group Holdings Parent (CON) Stock Analysis: Uncovering a 38.54% Potential Upside

Concentra Group Holdings Parent, Inc. (CON) emerges as an intriguing prospect for investors eyeing the healthcare sector, particularly within the medical care facilities industry. Based in..

Immunovant, Inc. (IMVT) Stock Analysis: A Biotech Gem with a 66% Upside Potential

Immunovant, Inc. (IMVT), a clinical-stage biotech firm, has recently captured the attention of investors seeking growth opportunities in the healthcare sector. With its focus on developing..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds